Status:
UNKNOWN
The Effect of Two Weeks of Voluntary Reduced Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Muscle Atrophy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is the most common pulmonary disease, responsible for considerable morbidity and mortality and is the third leading cause of death worldwide. As well as it...
Detailed Description
This is a non-commercial randomized controlled trial. 15 patients with COPD and 15 age-matched controls will voluntarily reduce their daily step-count to no more than 1500 steps/day, from a baseline o...
Eligibility Criteria
Inclusion
- Non-smoking adult patients with COPD (GOLD stage II-IV)
- Non-smoking, healthy, age-matched controls
- Baseline step count \> 3500 steps/day
- Baseline 6 minute walk distance \> 140m
Exclusion
- Inability to provide written, informed consent
- Significant co-morbidity limiting exercise tolerance
- Within 1 month of acute exacerbation of COPD
- Within 1 month of pulmonary rehabilitation
- History of venous thrombo-embolism or known increased risk of thrombotic disease
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2016
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT02221804
Start Date
May 1 2014
End Date
May 1 2016
Last Update
August 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton & Harefield NHS Foundation Trust
London, United Kingdom, SW3 6NP